Home | Contact Us | Brochure  | User Guide
0
Username
Password
Forgot Password
Capitaline Newswire App Google Play Capitaline Newswire App Store
02 Apr 2026 00:04 Sensex 73,319.55 185.23 (0.25%) || Nifty 22,713.10 33.70 (0.15%) 00
  AMC
  Single Scheme
  Multi Schemes
  Comparison
  NFO
  Charts
  MF Updates
  Miscellaneous
  Defined Sets
News
Top Equity Holdings by AMC
Interview with Fund Managers Back
24 Jan 2026 10:51
Zydus Lifesciences' Ankleshwar unit completes USFDA inspection
With 3 observations
Zydus Lifesciences announced that the USFDA conducted an inspection at the group's Unit – 2 manufacturing plant at Ankleshwar, Gujarat. The inspection was conducted from 19th to 23rd January, 2026 and concluded with 3 observations. There were no data integrity related observations. The Company will closely work with the USFDA to address the observations expeditiously.
Powered by Capital Market - Live News
Other Stories
Sun Pharma Advanced Resea...
 (3-Apr  13:04)
Ola Electric receives PLI...
 (3-Apr  13:02)
Pushpa Jewellers to condu...
 (3-Apr  11:45)
F Mec Intl. Financial Ser...
 (3-Apr  10:52)
Computer Age Management S...
 (3-Apr  10:52)
Medi Assist Healthcare Se...
 (3-Apr  10:49)
TPI India announces board...
 (3-Apr  10:23)
PAE to announce Quarterly...
 (3-Apr  10:23)
Bajaj Auto sells records ...
 (3-Apr  10:17)
Bajaj Auto records 20% gr...
 (3-Apr  10:13)
  FAQs  |  SEBI  |  AMFI  |  BSE  |  NSE
Glossary  |  Disclaimer   |  Privacy Policy   © Copyright 2022 All rights Reserved. Capital Market Publishers India Pvt. Ltd.